Phase I study of DKN-01 (D), an anti-DKK1 monoclonal antibody, in combination with gemcitabine (G) and cisplatin (C) in patients (pts) with advanced biliary cancer (ABC)

J. Eads, S. Stein, A. El-Khoueiry, G. Manji, T. Abrams, A. A. Khorana, R. Miksad, D. Mahalingam, C. Sirard, A. X. Zhu, L. Goyal

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)vi235
JournalAnnals of Oncology
StatePublished - Oct 1 2016

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this